We are live on ! Find out more
MRVI icon

Maravai LifeSciences

212 hedge funds and large institutions have $1.81B invested in Maravai LifeSciences in 2022 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 93 increasing their positions, 50 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 50

29% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 45

5% more funds holding

Funds holding: 202212 (+10)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3.08% less ownership

Funds ownership: 99.4%96.32% (-3.1%)

30% less call options, than puts

Call options by funds: $934K | Put options by funds: $1.34M

46% less capital invested

Capital invested by funds: $3.34B → $1.81B (-$1.53B)

Holders
212
Holders Change
+10
Holders Change %
+4.95%
% of All Funds
3.41%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
58
Increased
93
Reduced
50
Closed
45
Calls
$934K
Puts
$1.34M
Net Calls
-$405K
Net Calls Change
-$9.57M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$3.53M -$144K -9,118 -4%
Federated Hermes
52
Federated Hermes
Pennsylvania
$3.49M +$2.94M +186,467 +325%
LOAMS
53
Lombard Odier Asset Management (Switzerland)
Switzerland
$3.37M
First Trust Advisors
54
First Trust Advisors
Illinois
$3.34M -$408K -25,906 -10%
Public Sector Pension Investment Board (PSP Investments)
55
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.33M +$3.67M +233,000 New
GAM
56
Gotham Asset Management
New York
$3.31M +$1.89M +120,232 +108%
Bank Julius Baer & Co
57
Bank Julius Baer & Co
Switzerland
$3.18M +$118K +7,518 +4%
Jane Street
58
Jane Street
New York
$2.9M +$3.19M +202,321 New
APC
59
Alpine Peaks Capital
New York
$2.6M +$2.86M +181,500 New
Prudential Financial
60
Prudential Financial
New Jersey
$2.57M +$2.66M +168,699 +1,525%
Bank of America
61
Bank of America
North Carolina
$2.57M +$1.2M +76,126 +74%
SEC
62
Seven Eight Capital
New York
$2.54M +$2.79M +177,480 New
Janus Henderson Group
63
Janus Henderson Group
United Kingdom
$2.5M -$3.15M -200,253 -53%
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$2.31M +$382K +24,255 +18%
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
$2.23M +$518K +32,915 +27%
VOYA Investment Management
66
VOYA Investment Management
Georgia
$2.17M +$1.33M +84,274 +125%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$2.12M +$27.1K +1,720 +1%
ECM
68
ExodusPoint Capital Management
New York
$2.1M +$2.31M +146,667 New
Carson Wealth (CWM LLC)
69
Carson Wealth (CWM LLC)
Nebraska
$2.1M -$468K -29,749 -17%
National Bank of Canada
70
National Bank of Canada
Quebec, Canada
$1.89M +$2.08M +132,008 +528,032%
CS
71
Candriam SCA
Luxembourg
$1.86M +$2.05M +130,000 New
QT
72
Quantbot Technologies
New York
$1.82M +$2M +127,030 New
GC
73
Guggenheim Capital
Illinois
$1.7M +$1.87M +118,527 New
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.69M +$106K +6,749 +6%
CS
75
Credit Suisse
Switzerland
$1.55M -$18.6K -1,182 -1%

MRVI Hedge Fund Activity: Q4 2022 in Review

212 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q4 2022, worth a combined $1.81B — down 46% from $3.34B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new MRVI positions and 45 closed out — a net gain of 13 holders — while 93 added to existing stakes and 50 trimmed.

The largest buyer was Thrivent Financial for Lutherans, adding an estimated $57M. The largest seller was Select Equity Group, cutting an estimated $219M.

  • 212 institutional investors held Maravai LifeSciences (MRVI) as of Q4 2022, up from 202 in Q3 2022.
  • Funds reported $1.81B of Maravai LifeSciences stock for Q4 2022, down 46% quarter-over-quarter.
  • 58 funds opened new Maravai LifeSciences positions in Q4 2022 and 45 closed out, a net change of +13 holders.
  • The largest Maravai LifeSciences buyer in Q4 2022 was Thrivent Financial for Lutherans, an estimated $57M added.
  • The largest Maravai LifeSciences seller in Q4 2022 was Select Equity Group, an estimated $219M sold.

Based on aggregated 13F filings for Q4 2022.